BRIEF—Official launch of the RNA Centre for Excellence in UK

A new center to develop cutting-edge vaccines and therapeutics is set to open today in Darlington, UK.

The RNA Centre of Excellence has the capability to develop and manufacture treatments for incurable or hard-to-treat illnesses.

The Centre has the capacity to deliver 100 million vaccine doses in the event of a future health emergency.

But it will also supply material for clinical trials, working on treatments against infectious and non-infectious diseases – a critical step in getting new, more effective drugs to patients.

Having played a key role in the accelerated development of COVID-19 vaccines as part of the UK government’s Vaccine Taskforce, the Centre for Process Innovation (CPI) has built the knowledge and networks to support every stage of RNA development and scale-up.

It already working with pioneering partners to drive forward a variety of RNA projects, including a first-of-its-kind saRNA flu vaccine in collaboration with VaxEquity.